Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
100 studies found for:    Migraine AND 5-ht1 receptor
Show Display Options
Rank Status Study
1 Completed Determine Central 5-HT1B Receptor Occupancy of ZOMIG® Rapimelt (Zolmitriptan) in Healthy Male Volunteers
Condition: Migraine
Interventions: Drug: Rapimelt;   Drug: [11C]AZ10419369
2 Completed Zolmitriptan Nasal Spray Versus Eletriptan in the Acute Treatment of Migraine
Conditions: Acute Migraine;   Migraine Headache;   Headache Disorders
Interventions: Drug: Zolmitriptan 5 mg Nasal Spray;   Drug: Eletriptan 40 mg tablet
3 Completed
Has Results
Study of Telcagepant (MK-0974) in Participants With Moderate to Severe Acute Migraine With or Without Aura (MK-0974-011)
Condition: Migraine
Interventions: Drug: Telcagepant potassium 150 mg;   Drug: Telcagepant potassium 300 mg;   Drug: Zolmitriptan 5 mg;   Drug: Placebo to telcagepant 150 mg;   Drug: Placebo to tecagepant 300 mg;   Drug: Placebo to zolmitriptan 5 mg;   Drug: Rescue medication
4 Completed
Has Results
A Study to Determine the Effect of Sumatriptan and Naproxen Sodium Combination Tablet, Sumatriptan Tablet, and Naproxen Sodium Tablet on Blood Pressure When Treating Migraine Headaches That Occur During a 6-month Period
Conditions: Migraine With or Without Aura;   Migraine Disorders;   Migraine, Acute;   Migraine Headaches
Interventions: Drug: sumatriptan and naproxen sodium combination tablet;   Drug: sumatriptan tablet;   Drug: naproxen sodium tablet
5 Completed
Has Results
Long-Term Safety of Treximet (Sumatriptan/Naproxen Sodium) for Migraine in Adolescents
Condition: Migraine Disorders
Intervention: Drug: Combination Tablet of Treximet (sumatriptan/naproxen sodium)
6 Not yet recruiting Efficacy and Safety of a Fixed-dose Combination of Naratriptan and Naproxen in Acute Treatment of Migraine.
Conditions: Migraine;   Headache
Interventions: Drug: naratriptan + naproxen;   Drug: naratriptan;   Drug: naproxen
7 Completed Efficacy of Zolmitriptan (Zomig) in the Treatment of Migraines in Adolescents
Condition: Migraine
Interventions: Drug: Zolmitriptan;   Drug: Placebo
8 Completed ZAP, US. Zomig for Appropriate for Primary Care
Condition: Migraine
Intervention: Drug: Zolmitriptan
9 Unknown  Efficacy and Safety of a Fixed-dose Combination of Naratriptan and Naproxen in Acute Treatment of Migraine
Conditions: Migraine;   Headache
Interventions: Drug: Fixed-dose combination of naratriptan + naproxen;   Drug: Naratriptan;   Drug: Naproxen
10 Completed
Has Results
Zomig - Treatment of Acute Migraine Headache in Adolescents
Conditions: Migraine Headache;   Adolescents
Interventions: Drug: Zolmitriptan;   Drug: Placebo
11 Completed Dose Ranging Study of a Drug for the Treatment of Acute Migraine
Condition: Migraine - Acute
Interventions: Drug: Placebo matching BMS-927711;   Drug: BMS-927711;   Drug: Sumatriptan
12 Completed Phase I, Open Label, Single-Dose, Four Way Crossover Study to Compare the PK of NP101 With Oral Imitrex® (50mg) in Migraine Subjects During an Acute Migraine Attack and During a Non-Migraine Period
Condition: Migraine Disorders
Interventions: Drug: Sumatriptan succinate;   Drug: NP101 Study Patch
13 Completed
Has Results
Study to Evaluate the Efficacy and Safety of Oral Sumatriptan for the Acute Treatment of Migraine in Children and Adolescents
Conditions: Migraine Disorders;   Migraine
Interventions: Drug: Sumatriptan 25 mg;   Drug: Sumatriptan 50 mg;   Drug: Placebo
14 Completed Efficacy and Tolerability of Zolmitriptan Nasal Spray
Condition: Migraine
Interventions: Drug: Zolmitriptan;   Drug: Placebo
15 Completed
Has Results
Rizatriptan 5 mg and 10 mg, Sumatriptan 100 mg, and Placebo Comparison Study (0462-030)
Condition: Migraine Headache
Interventions: Drug: rizatriptan benzoate;   Drug: Comparator: sumatriptan;   Drug: Comparator: Placebo
16 Completed
Has Results
A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 1 of 2)
Conditions: Migraine With or Without Aura;   Migraine Disorders;   Migraine, Acute
Interventions: Drug: Combination Product (sumatriptan succinate / naproxen sodium);   Drug: Placebo
17 Completed
Has Results
A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 2 of 2)
Conditions: Migraine With or Without Aura;   Migraine Disorders;   Migraine
Interventions: Drug: Placebo;   Drug: Combination Product (sumatriptan succinate/naproxen sodium)
18 Completed
Has Results
Treximet Trademark (TM) in the Prevention and Modification of Disease Progression in Migraine
Condition: Migraine
Interventions: Drug: Sumatriptan/Naproxen Sodium;   Drug: Naproxen Sodium
19 Completed A Study to Assess an Auto-injector Being Used to Treat a Migraine Attack
Condition: Migraine
Intervention: Drug: "Investigational"Auto-injector (sumatriptan succinate)
20 Completed
Has Results
TREXIMET® Versus Butalbital-containing Combination Medications for the Acute Treatment of Migraine in Adults
Conditions: Migraine Disorders;   Migraine, Acute
Interventions: Drug: TREXIMET®;   Drug: Butalbital-containing Combination Medications (BCM);   Drug: placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years